Cardiomyopathy

PPG to Predict Ejection Fraction and Other Echographic Data in the General Population

Recruiting in Palo Alto (17 mi)

Overseen By Nassir Marrouche, MD

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Tulane University

No Placebo Group

Trial Summary

What is the purpose of this trial?

The investigators are aiming to investigate the association between ejection fraction (EF) determined by echocardiography and signals obtained from Photoplethysmography (PPG) in the general population. The investigators are also aiming to investigate the association between blood pressure and signals obtained from PPG in the general population. Finally, the investigators are also aiming to investigate the association between signals obtained from PPG in the general population to cardioechographic findings such as, valvular heart disease, structural heart diseases, cardiomyopathies, pericardial disease etc.

Eligibility Criteria

Participant Groups

Group I: Patient Group Experimental Treatment 1 Intervention

All patients undergoing an echocardiogram at Tulane Medical Center may be asked to participate in the study. Doctors, including PI and co-PI, will identify eligible patients from their clinic using their clinical knowledge and expertise and the patients' medical history and records. They will provide patients with information regarding the study and if interested, patients will be consented prior to their scheduled echocardiogram.

Find A Clinic Near You

Research locations nearby Select from list below to view details:

Tulane University Medical Center New Orleans, LA

Who is running the clinical trial?

Tulane University Lead Sponsor

References